fibrin formation and fibrinolysis were estimated in 89 breast cancer patients by measurement in plasma of fibrin fragment b beta 15-42 and fibrinopeptide a ( fpa ) , serum fibrin ( ogen ) degradation products ( fdps ) and plasminogen activator by fibrin plate lysis assay .
C0032105
plasma
C0015982
fibrin